534 related articles for article (PubMed ID: 35088962)
21. Feasibility of Indirect immunofluorescence (IIF) alone as a screening method for antinuclear antibody in connective diseases in India's sub-Himalayan region.
Kalita D; Rekha US; Raj AK; Mahanta P; Gupta P; Deka S
Indian J Pathol Microbiol; 2022; 65(4):873-878. PubMed ID: 36308197
[TBL] [Abstract][Full Text] [Related]
22. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis.
Tsouris Z; Liaskos C; Dardiotis E; Scheper T; Tsimourtou V; Meyer W; Hadjigeorgiou G; Bogdanos DP
Auto Immun Highlights; 2020 Dec; 11(1):7. PubMed ID: 32308974
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of the presence of autoantibodies in patients with toxocariasis].
Kaya S; Demirci M; Sesli Cetin E; Cicioğlu Aridoğan B; Sahin M; Taş T; Korkmaz M
Mikrobiyol Bul; 2009 Oct; 43(4):661-6. PubMed ID: 20084921
[TBL] [Abstract][Full Text] [Related]
26. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies testing.
Yumuk Z; Demir M
J Immunol Methods; 2020 May; 480():112754. PubMed ID: 32057435
[TBL] [Abstract][Full Text] [Related]
28. The Spectrum of Autoimmune Liver Disorders, Clinical Presentation, and Autoantibodies in Patients From a Tertiary Care Center in Pakistan.
Abbas Z; Asim M; Saeed A; Siddiqui B; Abbas M
Cureus; 2021 Nov; 13(11):e19789. PubMed ID: 34820249
[TBL] [Abstract][Full Text] [Related]
29. Clinical Aspects of the Dense Fine Speckled Pattern in Indirect Immunofluorescence-Antinuclear Antibody Screening and Its Association with DFS70 Autoantibodies.
La Jeon Y; Kang SY; Lee WI; Kim MH
Ann Clin Lab Sci; 2019 Sep; 49(4):496-502. PubMed ID: 31471339
[TBL] [Abstract][Full Text] [Related]
30. Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital.
Carter JB; Carter S; Saschenbrecker S; Goeckeritz BE
Front Med (Lausanne); 2018; 5():88. PubMed ID: 29686987
[TBL] [Abstract][Full Text] [Related]
31. Belimumab treatment in autoimmune hepatitis and primary biliary cholangitis - a case series.
Kolev M; Sarbu AC; Möller B; Maurer B; Kollert F; Semmo N
J Transl Autoimmun; 2023; 6():100189. PubMed ID: 36718275
[TBL] [Abstract][Full Text] [Related]
32. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases.
Strassburg CP; Alex B; Zindy F; Gerken G; Lüttig B; Meyer zum Büschenfelde KH; Bréchot C; Manns MP
J Hepatol; 1996 Dec; 25(6):859-66. PubMed ID: 9007714
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of autoimmune diseases and clinical significance of autoantibody profile: Data from National Institute of Hygiene in Rabat, Morocco.
Missoum H; Alami M; Bachir F; Arji N; Bouyahya A; Rhajaoui M; El Aouad R; Bakri Y
Hum Immunol; 2019 Jul; 80(7):523-532. PubMed ID: 30807792
[TBL] [Abstract][Full Text] [Related]
34. Analytical and clinical performance of different platforms simultaneously detecting 15 antinuclear antibodies.
Qin Y; Fan C; Wang Y; Feng M; Liang Z; Zhao X; Gao C; Luo J
J Clin Lab Anal; 2022 Jul; 36(7):e24554. PubMed ID: 35708068
[TBL] [Abstract][Full Text] [Related]
35. Clinical use of anti-DFS70 autoantibodies.
Kang SY; Lee WI; Kim MH; La Jeon Y
Rheumatol Int; 2019 Aug; 39(8):1423-1429. PubMed ID: 30972541
[TBL] [Abstract][Full Text] [Related]
36. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
37. Clinical value of chemiluminescence method for detection of antinuclear antibody profiles.
Xiang HY; Xiang XY; Ten TB; Ding X; Liu YW; Luo CH
World J Clin Cases; 2023 Oct; 11(28):6688-6697. PubMed ID: 37901001
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies by line immunoassay in patients with primary biliary cirrhosis.
Saito H; Takahashi A; Abe K; Okai K; Katsushima F; Monoe K; Kanno Y; Ohira H
Fukushima J Med Sci; 2012; 58(2):107-16. PubMed ID: 23237866
[TBL] [Abstract][Full Text] [Related]
39. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases.
Utiyama SR; Zenatti KB; Nóbrega HA; Soares JZ; Skare TL; Matsubara C; Muzzilo DA; Nisihara RM
Immunol Invest; 2016 Aug; 45(6):566-73. PubMed ID: 27409579
[TBL] [Abstract][Full Text] [Related]
40. Significance of extractable nuclear antigens in childhood autoimmune liver disease.
Gregorio GV; Davies ET; Mieli-Vergani G; Vergani D
Clin Exp Immunol; 1995 Nov; 102(2):308-13. PubMed ID: 7586683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
